Moderate riskFDA DrugClass II

Hikma ciprofloxacin 500 mg tablets recalled for N-nitroso impurity

Hikma Pharmaceuticals USA Inc. is recalling 29,085 bottles of Ciprofloxacin Tablets, USP, 500 mg, 100-count. The FDA found N-nitroso-ciprofloxacin levels above its recommended interim control limit, a problem under current good manufacturing practice (CGMP) rules. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Hikma Pharmaceuticals recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check the bottle for lot numbers CB496A, CB497A or CB498A, expiration date 12/31/2026, and NDC 0143-9928-01.
  3. The notice doesn't say how to get a refund or replacement; contact Hikma Pharmaceuticals USA Inc. or the pharmacy where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
29,085 bottles
Illnesses reported
None reported
Manufactured in
1809 Wilson Rd, Columbus, Ohio, United States
Classification
Class II
Recall number
D-0165-2027

In the FDA's words

Description
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01 CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit. Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026 Distribution: US Nationwide Affected quantity: 29,085 bottles
Hazard
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

2 products in this recall

The agency lists each product separately. Check every one you might have.

More from Hikma Pharmaceuticals

See all

Related topics

Unapproved drugsDrugsSold nationwideMore from FDA Drug